Jan 06, 2023 / 01:30PM GMT
Clare Trachtman - Baxter International Inc. - VP of IR
Good morning, everyone, and thank you for joining us on such short notice for Baxter's investor update. We are very excited to share with you the next phase of Baxter's transformation journey following a comprehensive strategic review we conducted over the last several months.
Joining me today are Joe Almeida, Baxter's Chairman and Chief Executive Officer; and Jay Saccaro, Baxter's Chief Financial Officer. On today's call, we will be discussing Baxter's proposed spinoff of the Renal Care and Acute Therapies global business units, Baxter's planned organizational redesign and further details surrounding actions to enhance our capital allocation profile including the review of strategic alternatives involving our BioPharma Solutions or BPS business.
We are excited to share with you the strategic rationale behind our plan to create 2 independent, leading healthcare companies and how we believe the spin will further enable strategic clarity and business simplification to accelerate each company's growth potential and deliver enhanced
Baxter International Inc Investor Call Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers